| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2007 | US20070004786 (5S)-2-Amino-5-(1-ethyl-5-propionyl-1H-pyrrol-3-yl)-5-[4-fluoro-3-(2-fluoropyridin-3-yl)phenyl]-3-methyl-3,5-dihydro-4H-imidazol-4-one; to treat Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits |
| 01/04/2007 | US20070004785 Modulators of sperm hypermotility and uses thereof |
| 01/04/2007 | US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents |
| 01/04/2007 | US20070004783 Crystalline forms of amlodipine maleate |
| 01/04/2007 | US20070004782 N-((2Z)-2-((4-Hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide Crystalline Form 2 |
| 01/04/2007 | US20070004781 Crystalline N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride |
| 01/04/2007 | US20070004780 Administering 2 to 8 mg per day of nontoxic insulin sensitiser rosiglitazone, and 500 mg or 850 mg of biguanide antihyperglycaemic agent; Type II diabetes |
| 01/04/2007 | US20070004779 Process for producing crystal |
| 01/04/2007 | US20070004778 New salts of omeprazole and esomeprazole i |
| 01/04/2007 | US20070004777 Methods for treating or preventing acute myelogenous leukemia |
| 01/04/2007 | US20070004776 2-amino-3-[4-(4-hydroxycarbamoylphenoxy)-phenyl]-propionic acids, esters and salts; antiinflammatory, antidiabetic, anticholesterol and hypoglycemic agents; metabolic disorders; inhibitors of TNF-alpha, IL-1 beta, IL-6, and IL-12 |
| 01/04/2007 | US20070004775 such as methyl-(2S)-2-[(3,5-dichloroisonicotinoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate, that are potent and selective inhibitors of alpha 4 integrins(VLA-4), having oral bioavailability, low clearance and high absorption, used for the treatment of VLA-4 dependent inflammatory diseases |
| 01/04/2007 | US20070004774 Cept inhibitors and metabolites thereof |
| 01/04/2007 | US20070004773 Amorphous salt of 4-(3-chiloro-4-(cycloproplylaminocarbonyl)aminophenoxy)-7-method-6-quinolinecarboxamide and process for preparing the same |
| 01/04/2007 | US20070004772 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure |
| 01/04/2007 | US20070004771 Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors |
| 01/04/2007 | US20070004770 Preventive agent/remedial agent for constipation predominant IBS |
| 01/04/2007 | US20070004769 For a novel and efficient synthesis of compounds in which the pharmacophores of quinolone and oxazolidinone are linked to one another by way of a chemically stable linker |
| 01/04/2007 | US20070004768 Hydroxamates of isoquinolines, imidazopyridines and pyrrolopyridines, used to treat AIDS and AIDS-related complex |
| 01/04/2007 | US20070004767 Methods for treating neurofibromatosis 1 |
| 01/04/2007 | US20070004766 Methods for relaxation of smooth muscle contractions using Trospium |
| 01/04/2007 | US20070004765 New compounds |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004763 Aminoquinoline and aminoquinazoline kinase modulators |
| 01/04/2007 | US20070004762 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 01/04/2007 | US20070004761 Pyrazolo [3,4-d] pyrimidine derivatives and their use in the treatment of h.pylori infection |
| 01/04/2007 | US20070004758 [2-Alkyl-3-(phenylaminocarbonyl)-4-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-5-(p-fluorophenyl)pyrrol-1-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; P38 map kinase inhibitors |
| 01/04/2007 | US20070004757 Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 01/04/2007 | US20070004756 Pharmaceutical compositions |
| 01/04/2007 | US20070004755 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/04/2007 | US20070004754 Substituted pyrazoles |
| 01/04/2007 | US20070004753 N-methyl-4-{4-[7-(4-cyano-3 -trifluoromethylphenyl)-6,8-dioxo-5,7-diazaspiro[3.4]oct-5-yl]-phenyl}butyramide; for treatment of hormone refractory prostate cancer |
| 01/04/2007 | US20070004752 serotonin, dopamin,muscarinic acetocholin, adrenergic receptors modulator; insomnia, hypersomnia, narcolepsy, sleep apnea syndrome, parasomnia, restless leg syndrome, and circadian rhythm abnormality; side effect reduction |
| 01/04/2007 | US20070004751 Substituted heterocyclic compounds |
| 01/04/2007 | US20070004749 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 01/04/2007 | US20070004748 Inhibition of osteolytic lesions by SRC kinase inhibitors |
| 01/04/2007 | US20070004747 Substituted pyrazoles |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004745 Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using PDE 5 inhibitors |
| 01/04/2007 | US20070004744 Prophylaxis and/or treatment of portal hypertension |
| 01/04/2007 | US20070004743 Intranasal administration of mc4-r agonists |
| 01/04/2007 | US20070004742 Arylpiperazinyl compounds |
| 01/04/2007 | US20070004741 N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004738 Substituted pyrazoles |
| 01/04/2007 | US20070004737 Process of purifying tadalafil |
| 01/04/2007 | US20070004736 Imidazole derivative, process for producing the same, and use |
| 01/04/2007 | US20070004735 Method for inhibiting the replication of herpes viruses |
| 01/04/2007 | US20070004734 For preparing 2,4-disubstituted pyrrolotriazine compounds |
| 01/04/2007 | US20070004733 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 01/04/2007 | US20070004732 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 01/04/2007 | US20070004731 N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1f][1,2,4]triazin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; allergies and asthma, Alzheimer's disease, rheumatoid arthritis, autoimmune diseases, bone diseases, inflammation |
| 01/04/2007 | US20070004730 e.g. 2-amino-5-[4-fluoro-3-(2-fluoropyridin-3-yl)phenyl]-3-methyl-5-pyridin-4-yl-3,5-dihydro-4H-imidazol-4-one; beta -amyloid deposits and neurofibrillary tangles blocking agent; neurodegenerative disorders, cognition activator; Alzheimer's disease, Down's Syndrome, senile dementia |
| 01/04/2007 | US20070004729 Methods and compositions of novel triazine compounds |
| 01/04/2007 | US20070004728 Reacting an aldehyde of triaryl N substituted oxazole with an azole in the presence of a carbonylating agent to give an oxazolidone; hydrolyzing the triarylmethyl group, cleave the oxygen bond, reacting with an amino protecting agent; then oxidizing |
| 01/04/2007 | US20070004727 Use of compounds for the prevention of drug-induced cell toxicity |
| 01/04/2007 | US20070004726 4-[2-(3-tert-Butyl-4-diethylaminophenyl)-2-hydroxyiminoethoxy]benzoic acid; modulates nuclear retinoic acid receptors; suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or into cosmetic compositions |
| 01/04/2007 | US20070004725 Novel derivatives of amino acids for treatment of obesity and related disorders |
| 01/04/2007 | US20070004724 (+)-(2S,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinor for treating anxiety |
| 01/04/2007 | US20070004723 To inhibit replication and/or proliferation of Hepatitis C virus; viral infections; 5-Dichloromethyl-3-[4-[3'-(2',6'-dichlorophenyl)-5'-isoxazolyl]phenyl]-1,2,4-oxadiazole |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/04/2007 | US20070004720 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 01/04/2007 | US20070004719 Inhibitors of cytosolic phospholipase A2 |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004717 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(-4-hydroxy-1-oxo-hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-methylbenzonitrile |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004715 Novel spiro-quinuclidinyl derivatives for the treatment of central nervous system disorders |
| 01/04/2007 | US20070004714 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004712 Salts of novel heterocyclic compounds having antibacterial activity |
| 01/04/2007 | US20070004711 Thiazole compounds and methods of use |
| 01/04/2007 | US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/04/2007 | US20070004709 excitatory amino acid receptors modulators; for the treatment or prevention of disorders of memory and cognition; 6-chloro-4-ethyl-3,4-dihydro-2H-thieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide; anxiety; depression; progressive neurodegenerative diseases |
| 01/04/2007 | US20070004708 1-{1-[1-(4-Methoxy-2-methylphenyl)-6-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-1H-pyrazol-3-yl}imidazolidin-2-one; potent; to treat central nervous system disorders; antidepressants; Anxiolytic agents; mood disorders; anagesics; gastrointestinal disorders like irritable bowel syndrome |
| 01/04/2007 | US20070004707 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride; schizophrenia, Parkinson's disease, psychosis associated with Lewy body disease, dementia, memory deficit; psychosis |
| 01/04/2007 | US20070004706 New polymorphs of olanzapine hydrochloride |
| 01/04/2007 | US20070004705 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/04/2007 | US20070004704 Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004702 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| 01/04/2007 | US20070004701 6-Chloro-[1,1';4',1'']terphenyl-3-carboxylic acid (2-methoxy-pyrimidin-5-yl)-amide; inhibiting topoisomerase; multi-drug resistant cancers |
| 01/04/2007 | US20070004700 for treatment of infections from pneumococci, Haemophilus influenzae, Moraxella (Branhamella) catarrhalis, and beta-lactamase producing bacteria |
| 01/04/2007 | US20070004699 Methods and compositions for treating atheroma, tumors and other neoplastic tissues |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | US20070004697 That do not react as readily with physiological thiols/disulfides and proteins may be markedly more effective against drug-resistant tumors than either cisplatin or the currently utilized analogs |
| 01/04/2007 | US20070004696 Monoazole ligand platinum analogs |
| 01/04/2007 | US20070004695 Thienoisoxazolyl-and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists |
| 01/04/2007 | US20070004694 Estrogen compositions for vaginal administration |
| 01/04/2007 | US20070004693 Estrogen compositions for vaginal administration |
| 01/04/2007 | US20070004692 Preparations and therapy of intrathecal inflammatory disease |
| 01/04/2007 | US20070004691 Antitumoral combinations containing et-743 and a cruciferous and a cruciferous indole compound |
| 01/04/2007 | US20070004690 Quadraphasis continuous graduated estrogen contraceptive |
| 01/04/2007 | US20070004689 Antiangiogenic agents |
| 01/04/2007 | US20070004688 Mixture with surfactant; bone disorders; controlling immunology response; cancer therapy |
| 01/04/2007 | US20070004687 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ll antagonist for stroke prevention |
| 01/04/2007 | US20070004685 Inhibition of thrombin generation |
| 01/04/2007 | US20070004684 Alpha-Carbolines as CDK-1 inhibitors |
| 01/04/2007 | US20070004683 Mao-b inhibitors useful for treating obesity |
| 01/04/2007 | US20070004682 diamino-substituted 1,2,5-oxadiazoles for treatment of cancer, gingivitis, antiatherosclerosis, as viricide, aniinflammatory agent, antiogenesis inhibitor and analgesic |